Peer-reviewed paper in 2026 shows mycelial compounds effective against respiratory diseases?
One-OffSanté et médecineScience2moisManifold MarketsSans KYCDonnées de résolution vérifiéesAssez bien calibréPrévision communautaire actuelleOui 81.4%
Prévisionnistes
12
Type de question
binary
Méthodologie
Play-money forecasting platform
Type de source
Prévision
Données du marché
Mis à jour il y a 16 heures
Obsolète12 nov. 25, 04:56 UTC31 déc. 26, 23:59 UTC
Tendances
Marchés Associés
Questions liées pour le contexte, et non une comparaison de contrats équivalents.
Will a peer-reviewed paper analyzing UAP sensor data be published in a Nature-family journal before January 1, 2027?
Manifold MarketsDate first peer reviewed manuscript in Cell, Nature, or Science concludes SARS2 lab origin more likely than not (Set)
Manifold MarketsWill China unveil a peer reviewed surgical cure for Alzheimers by the end of 2026?
Manifold MarketsWill a graviton be directly observed in a peer-reviewed paper before 2100?
Manifold MarketsWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiHow many human H5N1 cases will be reported in the United States in 2026?
KalshiRègles
Particularly against severe / pandemic-risk disease such as CoV-2, H5N1, or so on.
- Resolves YES if one is published which shows statistically significant effects using mushroom or mycelium-derived extracts or compounds.
- Otherwise NO at end of 2026.
